Revance Therapeutics Inc (RVNC)
$3.16
Revance Therapeutics Inc (RVNC) Share Price Forecast
Currently 18 wall-street analysts regularly analyze the financials of Revance Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 18 analysts offering 12-month price forecasts for Revance Therapeutics Inc (RVNC) have a share price target of $12.91. This median of share price forecast represents a 308.54% upside from the latest price of $3.16 as on 22.05.24.
Revance Therapeutics Inc (RVNC) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Revance Therapeutics Inc (RVNC) share price will touch around $12.91 in next 12-months.
Revance Therapeutics Inc (RVNC) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Revance Therapeutics Inc's share price and its median forecast price. As on 22.05.24, the difference is -70.6%
Revance Therapeutics Inc (RVNC): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Revance Therapeutics Inc (RVNC) Share Price : Analyst Recommendation
Based on 18 analysts tracking and researching Revance Therapeutics Inc (RVNC) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 10 | 10 | 10 |
| Outperform | 5 | 5 | 5 |
| Hold | 2 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 |
Revance Therapeutics Inc (RVNC) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Revance Therapeutics Inc (RVNC) is $12.91, offered by 18 analysts offering 12-month price forecasts.
Revance Therapeutics Inc (RVNC) has a maximum of 3.09 upside potential, based on 18 analysts offering 12-month price forecasts.
Based on 18 analysts tracking and researching Revance Therapeutics Inc (RVNC), 83.33% have a buy recommendation. Remaining 16.67% have either sell or hold recommendations.
The latest share price of Revance Therapeutics Inc (RVNC) is $3.16 as of 22/05/2024.
15 of total 18 analysts offering stock ratings for Revance Therapeutics Inc RVNC have recommended buy rating.
₹0 US Stocks a/c Opening Fee